The MFSD4 mRNA levels were not significantly associated with overall survival of the 200 enrolled patients (Supplementary Figure 2A), or overall (Supplementary Figure 2B) and disease-free survival (Supplementary Figure 2C) of patients with stage II/III GC. Here, SLC60A1 is linked to gastric cancer.